Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02282111 · ClinicalTrials.gov registry record · NA
EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT02282111: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT02282111 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02282111, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is a single-blinded randomized control trial trying to compare the effectiveness of diagnosis between two techniques employed in tissue sampling for subepithelial tumors (SETs) of the gastrointestinal tract. Over 2 years, patients having SET will be randomized to either get the EUS-guided core needle biopsy (EUS-CNB) or EUS-guided single-incision with needle knife (SINK) technique. This is of grave importance because the diagnosis of the myriad types of SETs is made histologically requiring a good sample.
Interventions
- DEVICE 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC)
- DEVICE conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02282111
The ClinicalTrials.gov registry entry for NCT02282111 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC) is the first listed.
NCT02282111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02282111 about?
NCT02282111 is a clinical study titled "EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors". This is a single-blinded randomized control trial trying to compare the effectiveness of diagnosis between two techniques employed in tissue sampling for subepithelial tumors (SETs) of the gastrointestinal tract. Over 2 years, patients having SET will be randomized to either get the EUS-guided core ...
What is the current status of trial NCT02282111?
This trial is currently terminated. It is a NA study. The enrollment target is 56 participants. The study started on 2014-07. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02282111?
The interventions under investigation include: 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC) (DEVICE), conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass) (DEVICE).
Who is sponsoring clinical trial NCT02282111?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.